Case File
efta-efta00696692DOJ Data Set 9OtherDS9 Document EFTA00696692
Date
Unknown
Source
DOJ Data Set 9
Reference
efta-efta00696692
Pages
2
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From:
To: "Jeffrey Epstein" <[email protected]>
Subject: Re: Fw: Deutsche Balm
Date: Fri, 25 Feb 2011 11:05:28 +0000
Importance: Normal
Tried cell.
What number ?
From: Jeffrey Epstein <[email protected]>
Date: Fri, 25 Feb 2011 05:59:18 -0500
To:
Subject: Re: Fw: Deutsche Bahn
call
On Fri, Feb 25, 2011 at 3:49 AM, <
> wrote:
Original Message------
From: Slaughter, Lawrence
To: David Stem
Subject: Deutsche Bahn
Sent: 25 Feb 2011 08:09
David,
With regards to Deutsche Bahn, I have asked my Beijing colleagues to stand down. They have stated that they
have not spoken to anyone at CIC with regards this topic.
Is this a practical case of where we could see if your approach makes sense?
If so, what is a concrete next step? I could send you a few pages which sets forth the basic concept as well as
some parameters.
Let me know what you think.
Regards,
Lany
Original Message
From: Slaughter, Lawrence
To:
Sent: Mon Feb 21 17:18:22 2011
Subject: Re: China
David,
It was a very interesting session - thanks for your time.
As a practical next step, let us keep talking about Deutsche Bahn.
EFTA00696692
Regards,
Larry
Original Message
From:
To: Slaughter, Lawrence
Sent: Mon Feb 21 16:11:40 2011
Subject: China
Larry,
Great pleasure meeting you. Thank you for your time.
All the best
David
This email is confidential and subject to important disclaimers and
conditions including on offers for the purchase or sale of
securities, accuracy and completeness of information, viruses,
confidentiality, legal privilege, and legal entity disclaimers,
available at http://www.jpmorgan.com/pages/disclosures/email.
The information contained in this communication is
confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for
the use of the addressee. It is the property of
Jeffrey Epstein
Unauthorized use, disclosure or copying of this
communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this
communication in error, please notify us immediately by
return e-mail or by e-mail to [email protected], and
destroy this communication and all copies thereof,
including all attachments. copyright -all rights reserved
EFTA00696693
Technical Artifacts (2)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Email
[email protected]URL
http://www.jpmorgan.com/pages/disclosures/emailRelated Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.